期刊
CLINICAL AND TRANSLATIONAL MEDICINE
卷 8, 期 1, 页码 -出版社
SPRINGEROPEN
DOI: 10.1186/s40169-019-0242-9
关键词
Mesenchymal stem cells; Extracellular vesicles; Acute respiratory distress syndrome; Acute lung injury
资金
- National Heart, Lung, and Blood Institute [R01HL127022]
Acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung condition associated with significant morbidity and mortality. Unfortunately, the current treatment for this disease is mainly supportive. Mesenchymal stem cells (MSCs) due to their immunomodulatory properties are increasingly being studied for the treatment of ARDS and have shown promise in multiple animal studies. The therapeutic effects of MSCs are exerted in part in a paracrine manner by releasing extracellular vesicles (EVs), rather than local engraftment. MSC-derived EVs are emerging as potential alternatives to MSC therapy in ARDS. In this review, we will introduce EVs and briefly discuss current data on EVs and MSCs in ARDS. We will discuss current literature on the role of MSC-derived EVs in pathogenesis and treatment of ARDS and their potential as a treatment strategy in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据